Sorafenib 10 mg | Purity Not Available StressMarq Biosciences Raf-1 kinase inhibitor More Information Supplier Page × Sorafenib
TG003 25 mg | Purity Not Available StressMarq Biosciences Clk family kinase inhibitor More Information Supplier Page × TG003
LFM A13 5 mg | Purity Not Available StressMarq Biosciences BTK kinase inhibitor More Information Supplier Page × LFM A13
(–)-Sinoacutine 5 mg | ≥95% Cayman Chemical An alkaloid with cytoprotective and vasorelaxant activities More Information Supplier Page × (–)-Sinoacutine
(–)-Sinoacutine 1 mg | ≥95% Cayman Chemical An alkaloid with cytoprotective and vasorelaxant activities More Information Supplier Page × (–)-Sinoacutine
(–)-Sinoacutine 500 µg | ≥95% Cayman Chemical An alkaloid with cytoprotective and vasorelaxant activities More Information Supplier Page × (–)-Sinoacutine
(–)-Sitagliptin (phosphate) 1 g | ≥98% Cayman Chemical A DPP-4 inhibitor More Information Supplier Page × (–)-Sitagliptin (phosphate)
(–)-Sitagliptin (phosphate) 250 mg | ≥98% Cayman Chemical A DPP-4 inhibitor More Information Supplier Page × (–)-Sitagliptin (phosphate)
(–)-Sitagliptin (phosphate) 100 mg | ≥98% Cayman Chemical A DPP-4 inhibitor More Information Supplier Page × (–)-Sitagliptin (phosphate)
(–)-Sitagliptin (phosphate) 50 mg | ≥98% Cayman Chemical A DPP-4 inhibitor More Information Supplier Page × (–)-Sitagliptin (phosphate)
(–)-Sitagliptin Carbamoyl Glucuronide 1 mg | ≥90% Cayman Chemical A minor phase II metabolite of (–)-sitagliptin More Information Supplier Page × (–)-Sitagliptin Carbamoyl Glucuronide
(–)-Sitagliptin Carbamoyl Glucuronide 500 µg | ≥90% Cayman Chemical A minor phase II metabolite of (–)-sitagliptin More Information Supplier Page × (–)-Sitagliptin Carbamoyl Glucuronide
(–)-Stepholidine 5 mg | ≥95% Cayman Chemical A dopamine receptor antagonist and 5-HT1A partial agonist More Information Supplier Page × (–)-Stepholidine